Tower Research Capital LLC (TRC) - TREVI THERAPEUTICS INC ownership

TREVI THERAPEUTICS INC's ticker is TRVI and the CUSIP is 89532M101. A total of 1 filers reported holding TREVI THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of TREVI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$14,068
+291.9%
6,453
+329.6%
0.00%
Q2 2023$3,590
-76.1%
1,502
-84.7%
0.00%
Q3 2022$15,000
+36.4%
9,786
+152.6%
0.00%
Q2 2022$11,000
-47.6%
3,874
-59.1%
0.00%
Q1 2022$21,000
+200.0%
9,477
+13.9%
0.00%
Q4 2021$7,0000.0%8,317
+73.2%
0.00%
Q3 2021$7,000
-30.0%
4,803
+14.7%
0.00%
Q2 2021$10,000
+233.3%
4,187
+238.5%
0.00%
Q1 2021$3,000
-76.9%
1,237
-76.3%
0.00%
Q4 2020$13,000
+116.7%
5,228
+271.6%
0.00%
Q3 2020$6,000
-45.5%
1,407
-40.0%
0.00%
-100.0%
Q3 2019$11,000
+22.2%
2,344
+95.0%
0.00%0.0%
Q2 2019$9,0001,2020.00%
Other shareholders
TREVI THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Omega Fund Management, LLC 1,375,907$9,053,0002.48%
NEA Management Company, LLC 5,940,796$39,090,0001.57%
TPG Group Holdings (SBS) Advisors, Inc. 4,824,883$31,748,0000.56%
BANCO BILBAO VIZCAYA ARGENTARIA, S.A. 70,000$460,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 100,000$658,0000.01%
FMR LLC 792,700$5,216,0000.00%
CANADA PENSION PLAN INVESTMENT BOARD 40,000$263,0000.00%
BlackRock Inc. 23,713$155,0000.00%
LPL Financial LLC 10,000$66,0000.00%
JPMORGAN CHASE & CO 3$00.00%
View complete list of TREVI THERAPEUTICS INC shareholders